It has been demonstrated that the BCR–ABL oncoprotein up-regulates HSP70 by binding the GATA–RE element to the HSP70 promoter region in chronic myelogenous leukemia (CML). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.